Will Garner
Biographic Data
| ID | 6069660 |
|---|---|
| NAME | Will Garner |
| GIVEN NAMES | Will |
| FAMILY NAME | Garner |
| SIGNATURE | GARNER W |
| AFFILIATIONS | Will Garner is with University Hospitals Cleveland Medical Center, Cleveland, OH. Brigid M. Wilson is with Geriatric Research Education and Clinical Center, Research Service, Louis Stokes Cleveland VA Medical Center, and Case Western School of Medicine, Department of Medicine, Division of Infectious Diseases and HIV Medicine, Cleveland. Marissa Maier is with VA Portland Health Care System, and Department of Internal Medicine, Division of Infectious Diseases, Oregon Health and Sciences University,... |
| ORCID | 0000-0003-0738-8696 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 2 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2016 |
| LATEST PUBLICATION YEAR | 2018 |
| H-INDEX | 1 |
Gaps in Preexposure Prophylaxis Uptake for HIV Prevention in the Veterans Health Administration
Objectives. To report demographics, regional variations, and indications for preexposure prophylaxis (PrEP) use for HIV prevention in the Veterans Health Administration (VHA). Methods. We identified persons initiating tenofovir/emtricitabine for the PrEP indication in the United States between July 2012 and April 2016 in a VHA national database. We stratified PrEP use by provider type and VHA region. We calculated PrEP initiation rate for each re…
Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretro…
This 96-week, randomized, open-label study was designed to assess the efficacy and safety of two single-tablet regimens in treatment naïve HIV-1-infected adults: rilpivirine (RPV) + emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) and efavirenz (EFV) + FTC/TDF. Assessments included patient-reported Medication Adherence Self-Report Inventory, SF-12v2 Quality of Life assessment, HIV Treatment Satisfaction Questionnaire, and HIV Symptom Index Q…
Gaps in Preexposure Prophylaxis Uptake for HIV Prevention in the Veterans Health Administration
Objectives. To report demographics, regional variations, and indications for preexposure prophylaxis (PrEP) use for HIV prevention in the Veterans Health Administration (VHA). Methods. We identified persons initiating tenofovir/emtricitabine for the PrEP indication in the United States between July 2012 and April 2016 in a VHA national database. We stratified PrEP use by provider type and VHA region. We calculated PrEP initiation rate for each re…
Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretro…
This 96-week, randomized, open-label study was designed to assess the efficacy and safety of two single-tablet regimens in treatment naïve HIV-1-infected adults: rilpivirine (RPV) + emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) and efavirenz (EFV) + FTC/TDF. Assessments included patient-reported Medication Adherence Self-Report Inventory, SF-12v2 Quality of Life assessment, HIV Treatment Satisfaction Questionnaire, and HIV Symptom Index Q…
Gaps in Preexposure Prophylaxis Uptake for HIV Prevention in the Veterans Health Administration
Objectives. To report demographics, regional variations, and indications for preexposure prophylaxis (PrEP) use for HIV prevention in the Veterans Health Administration (VHA). Methods. We identified persons initiating tenofovir/emtricitabine for the PrEP indication in the United States between July 2012 and April 2016 in a VHA national database. We stratified PrEP use by provider type and VHA region. We calculated PrEP initiation rate for each re…
Antiretroviral therapy (2 works) · Emtricitabine (2 works) · HIV/AIDS drug development and treatment (2 works) · HIV/AIDS Research and Interventions (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Adverse effect (1 work) · Cohort (1 work) · Demographics (1 work) · Demography (1 work)